Transfusion-related acute lung injury

American Journal of Nursing

Volumn 106, Issue 6, 2006, Pages 61-64

  Knippen, Maureen A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745098884     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200606000-00029     Document Type: Review

References (13)

1. Holness L, et al. Fatalities caused by TRALI. Transfus Med Rev 2004;18(3):184-8.
2. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951;51(20):2399-402.
3. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25(6):573-7.
4. Rizk A, et al. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001;41(2):264-8.
5. Win N, et al. Recurrent transfusion-related acute lung injury. Transfusion 2001;41(11):1421-5.
6. Kopko PM. Review: transfusion-related acute lung injury: pathophysiology, laboratory investigation, and donor management. Immunohematol 2004;20(2):103-11.
7. Goldman M, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005;19(1):2-31.
8. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 2003;43(12):1683-6.
9. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003;17(4):252-62.
10. Kopko PM, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001;41(10):1244-8.
11. Looney MR, et al. Transfusion-related acute lung injury: a review. Chest 2004;126(1):249-58.
12. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev 1999;13(3):177-86.
13. U.S. Food and Drug Administration. Current good manufacturing practice for blood and blood components: adverse reaction file. 21 CFR §606.170(b); 2002.